AceView: Gene:XPNPEP3andRBX1, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView.

cDNA accession Links to the sequence	Tissue most 5' clones in red	Match mRNA	From bp to bp in mRNA	From bp to bp in accs.	Clone encodes complete protein (with AA variation)	Features	Anomalies detected by AceView	Accession match over (% length)	Base differences relative to genome (% identity)
NM_022098.2		.a	1 to 3060	1 to 3060	exact	RefSeq,		3060/3060 (100 %)	0 diff (100 %id)
AL365514		.a	9 to 2773	1 to 2765	exact	tiling clone,		2765/2765 (100 %)	0 diff (100 %id)
BC001681	Lung, small cell carcinoma	.a	25 to 1735	1 to 1711	L486F	available from MGC, AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	1711/1711 (100 %)	1 diff (100.0 %id)
BC004989	Lung, small cell carcinoma	.a	25 to 1735	1 to 1711	exact	available from MGC, AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	1711/1711 (100 %)	0 diff (100 %id)
BE206978	lung, small cell carcinoma	.a	26 to 665	1 to 640			Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	640/640 (100 %)	9 diff (98.6 %id)
AK313770	testis	.a	31 to 1616	1 to 1586	exact			1586/1586 (100 %)	0 diff (100 %id)
DN995399	breast cancer, Mammary gland (cancer tissue)	.a	31 to 627	1 to 597				597/597 (100 %)	7 diff (98.9 %id)
DB036063	testis	.a	32 to 584	2 to 554		capped		553/553 (100 %)	0 diff (100 %id)
AU280088		.a	38 to 571	1 to 534				534/536 (99 %)	1 diff (99.9 %id)
CR456442		.a	56 to 1669	1 to 1614	exact			1614/1614 (100 %)	0 diff (100 %id)
BF312694	brain, neuroblastoma	.a	56 to 536	1 to 483				483/485 (99 %)	9 diff (98.2 %id)
BF315687	brain, neuroblastoma	.a	56 to 754	1 to 693				693/891 (77 %)	10 diff (98.9 %id)
BI199865	brain, neuroblastoma	.a	56 to 884	1 to 827				827/1050 (78 %)	27 diff (97.5 %id)
DB028060	testis	.a	66 to 599	2 to 535		capped		534/534 (100 %)	0 diff (100 %id)
DB270543	uterus	.a	66 to 607	2 to 543		capped		542/542 (100 %)	0 diff (100 %id)
TI_57197119		.a	68 to 883	20 to 837				818/874 (93 %)	20 diff (97.8 %id)
BE261625	brain, neuroblastoma	.a	76 to 558	1 to 483				483/485 (99 %)	1 diff (99.8 %id)
BI820933	pooled brain, lung, testis	.a	78 to 883	1 to 808				808/845 (95 %)	16 diff (98.2 %id)
CD631181		.a	80 to 196	8 to 124				117/125 (93 %)	7 diff (94.4 %id)
CD631182		.a	80 to 194	115 to 1				115/122 (94 %)	0 diff (100 %id)
CD631183		.a	80 to 196	8 to 124				117/125 (93 %)	7 diff (94.4 %id)
CD631184		.a	80 to 194	114 to 1				114/121 (94 %)	1 diff (99.2 %id)
CD631185		.a	80 to 196	8 to 123				116/124 (93 %)	8 diff (93.6 %id)
CD631186		.a	80 to 194	116 to 1				116/123 (94 %)	2 diff (98.4 %id)
CD631189		.a	80 to 196	8 to 124				117/125 (93 %)	7 diff (94.4 %id)
CD631190		.a	80 to 192	112 to 1				112/119 (94 %)	1 diff (99.2 %id)
TI_57174719		.a	82 to 758	36 to 717				682/717 (95 %)	17 diff (97.7 %id)
BI827371	brain, medulla	.a	83 to 758	1 to 682				682/682 (100 %)	14 diff (98.0 %id)
CD631187		.a	90 to 196	1 to 107				107/108 (99 %)	3 diff (97.3 %id)
CD631188		.a	90 to 196	107 to 1				107/107 (100 %)	1 diff (99.1 %id)
CR457396		.a	93 to 1614	1 to 1522				1522/1524 (99 %)	2 diff (99.9 %id)
CV026606	mixed	.a	93 to 669	1 to 577				577/577 (100 %)	8 diff (98.7 %id)
CU013328	Synthetic constructs	.a	93 to 1620	20 to 1547	exact			1528/1555 (98 %)	14 diff (99.1 %id)
CU013040	Synthetic constructs	.a	93 to 1618	20 to 1545	exact			1526/1558 (97 %)	7 diff (99.6 %id)
TI_1948080916		.a	93 to 878	127 to 913		fully sequenced,		787/913 (86 %)	16 diff (98.3 %id)
TI_1948081095		.a	93 to 885	131 to 924				794/1311 (60 %)	17 diff (98.8 %id)
TI_1948081270		.a	93 to 879	130 to 916				787/1257 (62 %)	11 diff (99.2 %id)
TI_1948081447		.a	93 to 840	133 to 880		fully sequenced,		748/880 (85 %)	8 diff (99.1 %id)
DW461981	Liver	.a	127 to 236	12 to 121				110/121 (90 %)	6 diff (95.1 %id)
TI_1948081448		.a	810 to 1618	939 to 120		fully sequenced,		820/939 (87 %)	16 diff (98.3 %id)
TI_1948080917		.a	847 to 1618	894 to 120		fully sequenced,		775/894 (86 %)	5 diff (99.5 %id)
TI_1948081271		.a	882 to 1618	855 to 117				739/1282 (57 %)	2 diff (99.9 %id)
TI_1948081096		.a	887 to 1618	854 to 120				735/1452 (50 %)	10 diff (99.4 %id)
CD359071	testis	.a	1000 to 1832	1 to 840				840/872 (96 %)	8 diff (99.1 %id)
BX099353	liver and spleen	.a	1194 to 1928	737 to 1			Submitted on the opposite strand	737/737 (100 %)	2 diff (99.8 %id)
AW732081	lung, small cell carcinoma	.a	1356 to 1735	400 to 21		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	380/380 (100 %)	3 diff (99.3 %id)
AI479803	anaplastic oligodendroglioma, brain	.a	1474 to 2123	656 to 7				650/660 (98 %)	0 diff (100 %id)
BE877442	large cell carcinoma, undifferentiated, lung	.a	1492 to 2141	1 to 648				648/871 (74 %)	8 diff (99.1 %id)
AA382300	testis	.a	1494 to 1735	1 to 242				242/242 (100 %)	0 diff (100 %id)
CX752771	Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass	.a	1514 to 2300	1 to 781			Submitted on the opposite strand	781/784 (99 %)	14 diff (98.3 %id)
EC539254	Prostate	.a	1631 to 1715	1 to 85				85/85 (100 %)	0 diff (100 %id)
AA700729	liver and spleen	.a	1858 to 2326	469 to 1				469/469 (100 %)	0 diff (100 %id)
AA699699	liver and spleen	.a	1897 to 2326	430 to 1				430/430 (100 %)	0 diff (100 %id)
R85448	liver and spleen	.a	1950 to 2319	377 to 3				375/377 (99 %)	0 diff (100 %id)
EC546488	Prostate	.a	1960 to 2059	16 to 113				98/113 (86 %)	6 diff (94.7 %id)
EC529688	Prostate	.a	2207 to 2314	1 to 107				107/107 (100 %)	5 diff (95.4 %id)
AI619443	moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus	.a	2253 to 2683	443 to 13		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	431/431 (100 %)	11 diff (97.5 %id)
AI623350	adenocarcinoma, Pancreas	.a	2257 to 2686	430 to 1				430/430 (100 %)	16 diff (96.3 %id)
AI292218	carcinoid, lung	.a	2293 to 2747	455 to 1				455/455 (100 %)	14 diff (97.0 %id)
BU631357	cell lines, Chondrosarcoma	.a	2362 to 3073	713 to 1		tiling clone,		713/713 (100 %)	6 diff (99.2 %id)
AI446638	poorly differentiated adenocarcinoma withsignet ring cell features, stomach	.a	2662 to 3060	399 to 1		tiling clone,		399/399 (100 %)	0 diff (100 %id)
AI311557	2 pooled tumors (clear cell type), Kidney	.a	2665 to 3067	403 to 1				403/403 (100 %)	13 diff (96.8 %id)
DB022029	testis	.b	1 to 555	2 to 559		tiling clone, capped		558/563 (99 %)	5 diff (99.2 %id)
AK301758	testis	.b	23 to 2271	1 to 2249	exact	tiling clone,		2249/2249 (100 %)	1 diff (100.0 %id)
DB023743	testis	.b	24 to 543	2 to 522		capped		521/521 (100 %)	1 diff (99.9 %id)
CD654136	Embryonic Stem cells	.b	555 to 1226	1 to 670				670/717 (93 %)	9 diff (98.8 %id)
BU186825	large cell carcinoma, lung	.b	1028 to 1480	1 to 460				460/727 (63 %)	9 diff (98.8 %id)
CD558137	testis	.b	1281 to 1610	1 to 332				332/886 (37 %)	3 diff (99.7 %id)
DB336029	testis	.b	1328 to 1876	549 to 1				549/549 (100 %)	0 diff (100 %id)
FN077010	breast carcinoma	.b	2166 to 2235	1 to 69				69/71 (97 %)	2 diff (97.2 %id)
DA238175	brain	.c	1 to 534	2 to 536		tiling clone, capped		535/535 (100 %)	1 diff (99.9 %id)
AL834310	testis	.c	30 to 2765	1 to 2736	exact	tiling clone, available from DKFZ, AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	2736/2736 (100 %)	0 diff (100 %id)
TI_57170195		.d	1 to 684	30 to 713		tiling clone,		684/713 (95 %)	7 diff (99.1 %id)
BI825148	brain, medulla	.d	9 to 684	1 to 675		tiling clone,		675/675 (100 %)	1 diff (99.9 %id)
BE788822	large cell carcinoma, lung	.d	640 to 1272	1 to 631		tiling clone,		631/631 (100 %)	4 diff (99.4 %id)
AK301635	esophagus, tumor tissue	.e	1 to 1042	3 to 1044	exact	tiling clone,		1044/1044 (100 %)	2 diff (99.9 %id)
DC393781	esophageal, tumor tissue	.e	1 to 562	3 to 564				564/564 (100 %)	2 diff (99.7 %id)
DB251140	uterus	.e	1 to 508	2 to 509		capped		508/508 (100 %)	0 diff (100 %id)
CN484448	eye	.e	12 to 630	1 to 619				619/619 (100 %)	5 diff (99.2 %id)
DA912613		.e	16 to 579	2 to 565		capped		564/564 (100 %)	1 diff (99.9 %id)
BC001208	Brain, neuroblastoma	.f	1 to 1084	4 to 1087	exact	tiling clone, available from MGC, AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	1087/1087 (100 %)	1 diff (100.0 %id)
BI260841	cervical carcinoma cell line, cervix	.g	1 to 805	1 to 806	E62R V63*	tiling clone,		806/807 (99 %)	13 diff (98.4 %id)
DW416315	Liver	.g	582 to 881	10 to 309		tiling clone,		300/309 (97 %)	12 diff (96.2 %id)
AA703314	liver and spleen	.g	638 to 1114	476 to 1		tiling clone,		476/476 (100 %)	6 diff (98.8 %id)
AK310502	testis	.h	1 to 1441	1 to 1441	exact	tiling clone,		1441/1441 (100 %)	0 diff (100 %id)
DB093050	testis	.h	2 to 551	2 to 553		capped		552/552 (100 %)	2 diff (99.7 %id)
DB024681	testis	.h	8 to 565	2 to 559		capped		558/558 (100 %)	0 diff (100 %id)
BI832228	brain, medulla	.h	10 to 695	10 to 697				688/698 (98 %)	9 diff (98.8 %id)
TI_57175980		.h	10 to 695	10 to 697				688/698 (98 %)	9 diff (98.8 %id)
BM800729	melanotic melanoma, skin	.i-u	1 to 839	23 to 862	exact	tiling clone, available from MGC,		840/1024 (82 %)	15 diff (98.6 %id)
BC037424	Skin, melanotic melanoma.	.i-u	2 to 936	1 to 935	exact	tiling clone, available from MGC, AAA		935/935 (100 %)	0 diff (100 %id)
DB477602	hippocampus	.i-u	9 to 503	1 to 495				495/495 (100 %)	2 diff (99.6 %id)
AV737639	cord Blood	.i-u	17 to 553	43 to 578				536/614 (87 %)	18 diff (97.1 %id)
BX119041		.i-u	18 to 409	1 to 392				392/392 (100 %)	0 diff (100 %id)
BE617460	adenocarcinoma, colon	.i-u	97 to 913	1 to 806				806/888 (90 %)	36 diff (96.0 %id)
BE617907	adenocarcinoma, colon	.i-u	101 to 889	791 to 1				791/791 (100 %)	4 diff (99.5 %id)
BM466568	eye, retinoblastoma	.i-u	139 to 937	19 to 825				807/938 (86 %)	18 diff (98.1 %id)
CA314208	Human Lung Epithelial cells, lung	.i-u	243 to 936	708 to 19		AAA		690/690 (100 %)	5 diff (99.3 %id)
CB409178	maxilla, pooled	.i-u	334 to 924	1 to 591				591/591 (100 %)	1 diff (99.9 %id)
CB409437	maxilla, pooled	.i-u	334 to 915	1 to 582				582/582 (100 %)	1 diff (99.9 %id)
BQ380466	uterus_tumor	.i-u	337 to 752	1 to 417				417/417 (100 %)	4 diff (99.1 %id)
BE940681	uterus_tumor	.i-u	341 to 791	13 to 459				447/460 (97 %)	12 diff (97.4 %id)
BE674036	carcinoid, lung	.i-u	346 to 937	596 to 5				592/596 (99 %)	0 diff (100 %id)
BQ380465	uterus_tumor	.i-u	383 to 731	360 to 16				345/360 (95 %)	0 diff (100 %id)
AA775784	whole brain	.i-u	399 to 937	542 to 1				542/542 (100 %)	31 diff (94.3 %id)
AW005574	anaplastic oligodendroglioma, brain	.i-u	412 to 937	527 to 2				526/527 (99 %)	0 diff (100 %id)
AI885037	anaplastic oligodendroglioma, brain	.i-u	434 to 935	517 to 16		AAA		502/502 (100 %)	1 diff (99.9 %id)
AI127653	uterus	.i-u	462 to 942	480 to 2				479/480 (99 %)	0 diff (100 %id)
AI471784	Kidney	.i-u	467 to 936	470 to 1				470/470 (100 %)	0 diff (100 %id)
AW002166	thymus, pooled	.i-u	531 to 937	411 to 4				408/411 (99 %)	0 diff (100 %id)
AI652199	pooled germ cell tumors	.i-u	543 to 936	394 to 1				394/396 (99 %)	1 diff (99.8 %id)
AA398384		.i-u	550 to 935	389 to 4				386/389 (99 %)	0 diff (100 %id)
DB546196	hippocampus	.i-u	608 to 936	1 to 329			Submitted on the opposite strand	329/329 (100 %)	2 diff (99.4 %id)
AW593748	pooled germ cell tumors	.i-u	675 to 936	262 to 1				262/262 (100 %)	0 diff (100 %id)
C21259		.i-u	758 to 940	1 to 183				183/183 (100 %)	0 diff (100 %id)
BP346902	brain	.j	1 to 575	8 to 582	exact	tiling clone,		582/582 (100 %)	1 diff (99.9 %id)
CN257899	embryonic stem cells, DMSO-treated H9 cellline	.k	-8 to 451	1 to 460	exact	tiling clone,		460/460 (100 %)	0 diff (100 %id)
BG497476	adenocarcinoma, Prostate	.k	36 to 671	1 to 636				636/636 (100 %)	1 diff (99.9 %id)
CN257897	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.k	82 to 805	1 to 724		tiling clone,		724/724 (100 %)	1 diff (99.9 %id)
N23017	melanocyte	.l	1 to 490	495 to 2	N16K A17C V18Q A19V L20X ...	tiling clone,		492/495 (99 %)	13 diff (97.4 %id)
FN086918	breast carcinoma	.m	1 to 90	89 to 1		tiling clone,	Submitted on the opposite strand	89/89 (100 %)	2 diff (97.8 %id)
BU533420	mixed (pool of 40 RNAs)	.m	23 to 568	1 to 546	exact			546/551 (99 %)	3 diff (99.5 %id)
BG339057	leiomyosarcoma cell line, uterus	.m	25 to 476	1 to 452	exact	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	452/452 (100 %)	1 diff (99.8 %id)
BU533405	mixed (pool of 40 RNAs)	.m	29 to 566	1 to 538	exact			538/539 (99 %)	2 diff (99.7 %id)
BU597842	mixed (pool of 40 RNAs)	.m	35 to 568	1 to 534	exact			534/570 (93 %)	7 diff (98.8 %id)
BU861191	mixed (pool of 40 RNAs)	.m	35 to 564	1 to 530	exact			530/563 (94 %)	2 diff (99.7 %id)
BU941262	mixed (pool of 40 RNAs)	.m	35 to 549	1 to 515	exact			515/545 (94 %)	2 diff (99.7 %id)
CD051073	embryonic trophoblasts, made from WA01 stemcells	.m	38 to 566	23 to 550	A3V	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	528/550 (96 %)	6 diff (99.0 %id)
BU958173	mixed (pool of 40 RNAs)	.m	38 to 568	1 to 531	A43S			531/564 (94 %)	6 diff (99.0 %id)
CD172680	embryonic stem cells, WA01, passage 38	.m	39 to 566	18 to 544	A2R A3F A4R M5W D6M ...	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	527/544 (96 %)	6 diff (98.9 %id)
DA528969	brain	.m	39 to 633	2 to 596	exact	tiling clone, capped		595/595 (100 %)	0 diff (100 %id)
CD249363	embryonic stem cells, WA01, passage 38	.m	40 to 565	10 to 533	exact	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	524/533 (98 %)	7 diff (98.7 %id)
BF956282	nervous_normal	.m	41 to 445	1 to 405	exact			405/405 (100 %)	4 diff (99.1 %id)
BU858782	mixed (pool of 40 RNAs)	.m	42 to 568	1 to 527	I44L			527/557 (94 %)	6 diff (99.0 %id)
CB999822	Pooled-Skin	.m	42 to 564	1 to 523	exact			523/527 (99 %)	3 diff (99.5 %id)
CN305890	embryonic stem cells, DMSO-treated H9 cellline	.m	43 to 504	1 to 462	exact			462/462 (100 %)	5 diff (99.0 %id)
BU932751	mixed (pool of 40 RNAs)	.m	43 to 567	1 to 525	exact			525/527 (99 %)	4 diff (99.3 %id)
BG534675	lung	.m	44 to 568	1 to 526	N98S			526/653 (80 %)	6 diff (99.1 %id)
BG777485	adenocarcinoma, Prostate	.m	44 to 529	1 to 487	exact			487/488 (99 %)	4 diff (99.2 %id)
CB857843	anterior tongue, pooled	.m	44 to 521	1 to 478	exact			478/478 (100 %)	3 diff (99.4 %id)
CD523457	pooled	.m	44 to 567	1 to 525	exact			525/531 (98 %)	5 diff (99.1 %id)
CK003869	brain/CNS, Human Brain - Cerebellar Cortex	.m	44 to 564	1 to 521	exact	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	521/521 (100 %)	3 diff (99.5 %id)
CD388268	embryonic trophoblasts, made from WA01 stemcells	.m	45 to 571	12 to 537	exact	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	526/537 (97 %)	6 diff (98.9 %id)
CF124625	CNCAP(3)T-225 cell line, Prostate	.m	45 to 566	38 to 559	exact	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	522/559 (93 %)	7 diff (98.8 %id)
BU601080	mixed (pool of 40 RNAs)	.m	45 to 568	1 to 524	exact			524/555 (94 %)	3 diff (99.5 %id)
BU954591	mixed (pool of 40 RNAs)	.m	45 to 565	1 to 521	exact			521/523 (99 %)	4 diff (99.3 %id)
TI_154184975		.m	45 to 566	107 to 628	exact	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	522/552 (94 %)	7 diff (98.8 %id)
AV715190		.m	46 to 566	1 to 521	exact	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	521/521 (100 %)	3 diff (99.5 %id)
BU594675	mixed (pool of 40 RNAs)	.m	46 to 568	1 to 523	exact			523/527 (99 %)	4 diff (99.3 %id)
BF679205	Prostate	.m	47 to 565	1 to 512	I37M V38W V39L D40I N41T ...	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	512/512 (100 %)	9 diff (98.3 %id)
BG531117	embryonal carcinoma, testis	.m	47 to 450	1 to 403	exact			403/403 (100 %)	8 diff (98.1 %id)
BM757406	Ascites, stomach	.m	47 to 562	14 to 529	exact			516/516 (100 %)	0 diff (100 %id)
CD175085	embryonic stem cells, WA01, passage 38	.m	48 to 566	23 to 540	exact	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	518/540 (95 %)	7 diff (98.8 %id)
CR456560		.m	48 to 582	1 to 535	exact			535/535 (100 %)	0 diff (100 %id)
DW411008	Liver	.m	48 to 361	18 to 331				314/331 (94 %)	6 diff (98.2 %id)
BC017370	Brain, glioblastoma	.m	48 to 567	5 to 524	exact	available from MGC, AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	520/521 (99 %)	2 diff (99.7 %id)
BG478622	melanotic melanoma, skin	.m	48 to 565	1 to 518	exact	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	518/518 (100 %)	0 diff (100 %id)
BG705958	brain, hypothalamus	.m	48 to 566	1 to 519	exact	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	519/519 (100 %)	4 diff (99.3 %id)
CB121873	Liver	.m	48 to 289	1 to 242				242/242 (100 %)	1 diff (99.6 %id)
NM_014248.2		.m	48 to 568	1 to 521	exact	RefSeq,		521/521 (100 %)	0 diff (100 %id)
BI198015	brain, neuroblastoma	.m	49 to 568	1 to 527	exact			527/546 (96 %)	8 diff (98.6 %id)
BU601301	mixed (pool of 40 RNAs)	.m	50 to 568	1 to 519	exact			519/521 (99 %)	5 diff (99.1 %id)
BU955646	mixed (pool of 40 RNAs)	.m	50 to 565	1 to 516	exact			516/517 (99 %)	4 diff (99.3 %id)
DT220847	brain	.m	53 to 791	1 to 738	exact			738/738 (100 %)	1 diff (99.9 %id)
DB475306	hippocampus	.m	53 to 528	1 to 476	exact			476/476 (100 %)	0 diff (100 %id)
CB137618	Liver	.m	53 to 565	1 to 512	H82R	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	512/512 (100 %)	5 diff (99.1 %id)
BP308845	brain	.m	53 to 565	1 to 513	exact	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	513/513 (100 %)	0 diff (100 %id)
DA003707		.m	54 to 627	2 to 576	D8G V70C A71R W72M V74S ...	capped		575/575 (100 %)	2 diff (99.7 %id)
DA466653	cord Blood	.m	54 to 566	2 to 515	exact	capped		514/524 (98 %)	2 diff (99.7 %id)
BU601181	mixed (pool of 40 RNAs)	.m	54 to 566	1 to 513	exact			513/513 (100 %)	4 diff (99.3 %id)
BU532840	mixed (pool of 40 RNAs)	.m	54 to 571	1 to 518	exact			518/527 (98 %)	3 diff (99.5 %id)
AK315722	testis	.m	55 to 392	1 to 338	exact			338/338 (100 %)	0 diff (100 %id)
AL711573	human skeletal muscle	.m	55 to 567	10 to 522	exact			513/513 (100 %)	0 diff (100 %id)
BP317451	pericardium	.m	55 to 566	1 to 513	exact			513/521 (98 %)	4 diff (99.3 %id)
DA150258	amygdala	.m	56 to 290	2 to 236		capped		235/235 (100 %)	1 diff (99.6 %id)
DB493781	hypothalamus	.m	56 to 562	1 to 507	D8G			507/507 (100 %)	3 diff (99.5 %id)
DB493801	hypothalamus	.m	56 to 546	1 to 491	D8G			491/497 (98 %)	4 diff (99.2 %id)
DB501198	hypothalamus	.m	56 to 550	1 to 495	D8G			495/495 (100 %)	3 diff (99.4 %id)
BM459634	leiomyosarcoma, uterus	.m	56 to 954	1 to 899	exact	tiling clone,		899/904 (99 %)	8 diff (99.2 %id)
DB090580	testis	.m	56 to 568	2 to 514	exact	capped		513/519 (98 %)	1 diff (99.9 %id)
BF821575	kidney_tumor	.m	57 to 332	274 to 1			Submitted on the opposite strand	274/274 (100 %)	1 diff (99.7 %id)
BE735168	choriocarcinoma, placenta	.m	57 to 566	1 to 510	A4L	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	510/510 (100 %)	7 diff (98.7 %id)
CU013448	Synthetic constructs	.m	57 to 389	11 to 343				333/358 (93 %)	6 diff (98.4 %id)
CU013160	Synthetic constructs	.m	57 to 396	11 to 350	exact			340/361 (94 %)	12 diff (96.7 %id)
BP316685	pericardium	.m	59 to 566	1 to 508	V39D E66G R86C	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	508/508 (100 %)	9 diff (98.3 %id)
AF140598		.m	60 to 566	1 to 508	exact			508/508 (100 %)	2 diff (99.7 %id)
BX283972	choriocarcinoma, placenta	.m	60 to 532	1 to 473	exact			473/473 (100 %)	1 diff (99.8 %id)
CD673786	eye, lens	.m	60 to 566	1 to 507	R46M V74A	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	507/507 (100 %)	4 diff (99.3 %id)
BP420485	small intestine	.m	60 to 568	8 to 516	exact		Submitted on the opposite strand	509/518 (98 %)	7 diff (98.7 %id)
BG337472	leiomyosarcoma cell line, uterus	.m	60 to 566	1 to 507	exact	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	507/507 (100 %)	1 diff (99.9 %id)
AA379991	skin	.m	61 to 272	1 to 211				211/211 (100 %)	2 diff (99.1 %id)
BC001466	Placenta, choriocarcinoma	.m	61 to 566	1 to 506	exact	available from MGC, AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	506/506 (100 %)	0 diff (100 %id)
CN305892	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	.m	61 to 568	1 to 508	exact			508/509 (99 %)	7 diff (98.7 %id)
D52876		.m	62 to 253	1 to 192		fully sequenced,		192/192 (100 %)	0 diff (100 %id)
CD686718	normal nasopharynx	.m	63 to 328	1 to 266				266/266 (100 %)	4 diff (98.5 %id)
BU729963	eye, Retina Foveal and Macular	.m	63 to 565	521 to 19	exact	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	503/515 (97 %)	0 diff (100 %id)
BM715215	eye, human retina	.m	63 to 565	1 to 503	exact	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	503/503 (100 %)	0 diff (100 %id)
TI_153984959		.m	63 to 565	55 to 557	exact	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	503/503 (100 %)	0 diff (100 %id)
BE566728	bladder, carcinoma, cell line	.m	64 to 554	1 to 489	K25N W27V N28E A29C V30S ...			487/803 (60 %)	20 diff (97.6 %id)
BQ220259	melanotic melanoma, skin	.m	64 to 568	1 to 505	N14T S15A G16A A17R G18A ...			505/509 (99 %)	3 diff (99.5 %id)
AA345277	gall bladder	.m	65 to 381	1 to 316				316/316 (100 %)	1 diff (99.7 %id)
AF142059		.m	66 to 392	1 to 327	exact			327/327 (100 %)	0 diff (100 %id)
BE737604	brain, glioblastoma	.m	67 to 568	1 to 493				493/700 (70 %)	11 diff (98.5 %id)
BE738587	brain, glioblastoma	.m	67 to 514	448 to 1				448/448 (100 %)	5 diff (98.9 %id)
AI750496	Bone, Hip	.m	67 to 506	1 to 440				440/440 (100 %)	7 diff (98.5 %id)
BM711445	eye, fetal eyes	.m	67 to 553	1 to 487		fully sequenced,	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	487/487 (100 %)	4 diff (99.2 %id)
BE728298	melanotic melanoma, skin	.m	68 to 564	1 to 498				498/498 (100 %)	3 diff (99.4 %id)
BF684301	leiomyosarcoma cell line, uterus	.m	68 to 566	1 to 499		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	499/499 (100 %)	1 diff (99.8 %id)
CN305893	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	.m	69 to 566	1 to 498		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	498/498 (100 %)	0 diff (100 %id)
CN305897	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	.m	69 to 321	1 to 253				253/253 (100 %)	0 diff (100 %id)
BE298380	muscle, rhabdomyosarcoma	.m	69 to 734	1 to 660				660/748 (88 %)	19 diff (97.5 %id)
CN305889	embryonic stem cells, DMSO-treated H9 cellline	.m	70 to 565	1 to 496				496/496 (100 %)	6 diff (98.8 %id)
AV751916	Pituitary	.m	70 to 566	20 to 516		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	497/516 (96 %)	6 diff (98.9 %id)
CN305887	embryonic stem cells, DMSO-treated H9 cellline	.m	72 to 568	1 to 497				497/503 (98 %)	5 diff (99.1 %id)
BM045028	carcinoma, cell line, Prostate	.m	72 to 894	1 to 826				826/826 (100 %)	5 diff (99.4 %id)
BM808337	amelanotic melanoma, cell line, skin	.m	72 to 566	1 to 495		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	495/495 (100 %)	0 diff (100 %id)
BU957127	adenocarcinoma, cell line, breast	.m	72 to 565	1 to 494				494/495 (99 %)	1 diff (99.8 %id)
BU957594	adenocarcinoma, cell line, breast	.m	72 to 567	1 to 496				496/500 (99 %)	1 diff (99.8 %id)
AW365113	denis_drash	.m	73 to 446	372 to 1				372/372 (100 %)	8 diff (97.9 %id)
AW365115	denis_drash	.m	73 to 437	369 to 7				363/369 (98 %)	4 diff (99.0 %id)
BF348984	denis_drash	.m	73 to 434	370 to 7				364/371 (98 %)	19 diff (94.9 %id)
CN305888	embryonic stem cells, DMSO-treated H9 cellline	.m	73 to 566	1 to 494		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	494/494 (100 %)	0 diff (100 %id)
CB113476	Liver	.m	74 to 184	1 to 111				111/111 (100 %)	0 diff (100 %id)
CN305894	embryonic stem cells, DMSO-treated H9 cellline	.m	75 to 565	1 to 491		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	491/491 (100 %)	0 diff (100 %id)
BG830409	epithelioid carcinoma cell line, Pancreas	.m	76 to 565	1 to 490		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	490/490 (100 %)	2 diff (99.6 %id)
BQ670844	epidermoid carcinoma, cell line, salivary gland	.m	76 to 566	1 to 491		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	491/491 (100 %)	0 diff (100 %id)
BM697883	eye, fetal eyes	.m	78 to 465	1 to 388		fully sequenced,	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	388/388 (100 %)	0 diff (100 %id)
AW365093	denis_drash	.m	79 to 437	360 to 4				357/361 (98 %)	6 diff (98.4 %id)
BQ340511	nervous_normal	.m	79 to 445	1 to 365				365/365 (100 %)	4 diff (99.0 %id)
BE280480	choriocarcinoma, placenta	.m	80 to 566	1 to 487		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	487/487 (100 %)	0 diff (100 %id)
BM702796	eye, Retina Foveal and Macular	.m	80 to 565	14 to 500				487/500 (97 %)	6 diff (98.8 %id)
BG108717	retina, Retinal Pigment Epithelium sheets	.m	81 to 415	1 to 333				333/333 (100 %)	5 diff (98.5 %id)
BQ340343	nervous_normal	.m	81 to 445	1 to 365				365/365 (100 %)	2 diff (99.5 %id)
AA745280	Ewing's sarcoma	.m	81 to 509	1 to 426				426/426 (100 %)	8 diff (98.2 %id)
BM452435	eye, retinoblastoma	.m	81 to 566	1 to 486		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	486/486 (100 %)	0 diff (100 %id)
BQ880298	epidermoid carcinoma, cell line, salivary gland	.m	82 to 566	1 to 485		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	485/485 (100 %)	0 diff (100 %id)
DB572386	hypothalamus	.m	83 to 565	1 to 483			Submitted on the opposite strand	483/483 (100 %)	1 diff (99.8 %id)
AA308774	colon	.m	84 to 571	1 to 489				489/489 (100 %)	3 diff (99.4 %id)
W76640	heart	.m	84 to 324	1 to 241		fully sequenced,		241/241 (100 %)	5 diff (98.0 %id)
W79713	heart	.m	84 to 351	1 to 267		fully sequenced,		267/267 (100 %)	9 diff (96.7 %id)
BG112117	Bone, osteosarcoma, cell line	.m	84 to 565	1 to 483				483/504 (95 %)	5 diff (99.1 %id)
AF085906		.m	85 to 571	1 to 487		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	487/487 (100 %)	0 diff (100 %id)
BY800217	eye	.m	86 to 565	11 to 490				480/491 (97 %)	7 diff (98.6 %id)
CB158352	Liver	.m	86 to 565	1 to 480		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	480/480 (100 %)	1 diff (99.8 %id)
BE256643	eye, retinoblastoma	.m	88 to 566	1 to 479		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	479/479 (100 %)	0 diff (100 %id)
AA707907	pineal gland	.m	89 to 565	478 to 1				478/478 (100 %)	7 diff (98.6 %id)
AI022229	liver and spleen	.m	89 to 568	482 to 3				480/482 (99 %)	1 diff (99.8 %id)
AI041107		.m	92 to 568	481 to 6				476/484 (98 %)	1 diff (99.8 %id)
BU507446	leiomyosarcoma, uterus	.m	92 to 567	1 to 476				476/476 (100 %)	0 diff (100 %id)
BU853445	testis	.m	92 to 568	1 to 477				477/509 (93 %)	4 diff (99.3 %id)
DB544129	hippocampus	.m	93 to 566	1 to 474			Submitted on the opposite strand	474/474 (100 %)	0 diff (100 %id)
BE855958	Prostate	.m	94 to 568	479 to 3				477/479 (99 %)	3 diff (99.4 %id)
BG338194	leiomyosarcoma cell line, uterus	.m	96 to 566	1 to 471		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	471/471 (100 %)	1 diff (99.8 %id)
AA740169	2 pooled tumors (clear cell type), Kidney	.m	98 to 568	476 to 8				469/476 (98 %)	4 diff (99.2 %id)
AA315816	colon	.m	99 to 571	1 to 473				473/474 (99 %)	1 diff (99.8 %id)
N41413	placenta	.m	99 to 566	1 to 466		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	466/466 (100 %)	5 diff (99.0 %id)
AA598700	lung, lung carcinoma	.m	99 to 565	466 to 2				465/466 (99 %)	4 diff (99.2 %id)
BE386254	melanotic melanoma, skin	.m	99 to 564	1 to 466				466/466 (100 %)	2 diff (99.6 %id)
AV753001	Pituitary	.m	99 to 566	1 to 468		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	468/468 (100 %)	3 diff (99.4 %id)
F25684	pectoral muscle (after mastectomy)	.m	100 to 472	1 to 373				373/373 (100 %)	0 diff (100 %id)
AY099360	whole brain	.m	103 to 408	1 to 306				306/306 (100 %)	1 diff (99.7 %id)
BF822476	kidney_tumor	.m	104 to 508	408 to 3			Submitted on the opposite strand	406/423 (95 %)	8 diff (98.2 %id)
AI266102	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.m	106 to 568	464 to 1				464/467 (99 %)	9 diff (98.1 %id)
AA701641	liver and spleen	.m	107 to 566	458 to 1				458/458 (100 %)	4 diff (99.2 %id)
BE407935	choriocarcinoma, placenta	.m	107 to 565	1 to 459		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	459/459 (100 %)	0 diff (100 %id)
AA991432	pooled germ cell tumors	.m	108 to 518	410 to 1				410/410 (100 %)	3 diff (99.3 %id)
DB564831	hypothalamus	.m	109 to 565	1 to 457			Submitted on the opposite strand	457/457 (100 %)	0 diff (100 %id)
BG054985	brain, glioblastoma (pooled)	.m	112 to 566	455 to 1				455/455 (100 %)	0 diff (100 %id)
AA704484	liver and spleen	.m	114 to 565	450 to 1				450/450 (100 %)	6 diff (98.7 %id)
BF747781	breast	.m	115 to 385	324 to 57			Submitted on the opposite strand	267/324 (82 %)	8 diff (97.6 %id)
CN305896	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.m	115 to 258	1 to 144				144/144 (100 %)	0 diff (100 %id)
BU927779	mixed (pool of 40 RNAs)	.m	117 to 568	1 to 452				452/458 (98 %)	2 diff (99.6 %id)
AA722697	heart	.m	120 to 568	451 to 5				447/451 (99 %)	4 diff (99.2 %id)
AA699317	liver and spleen	.m	120 to 566	445 to 1				445/445 (100 %)	6 diff (98.7 %id)
AA977173	pooled germ cell tumors	.m	120 to 566	456 to 11		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	446/446 (100 %)	5 diff (98.9 %id)
AI129338	uterus	.m	120 to 565	458 to 13		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	446/446 (100 %)	4 diff (99.2 %id)
AI190633	heart	.m	120 to 566	457 to 11		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	447/447 (100 %)	1 diff (99.8 %id)
AI299232	2 pooled tumors (clear cell type), Kidney	.m	120 to 566	457 to 11		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	447/447 (100 %)	2 diff (99.6 %id)
AI310807	2 pooled tumors (clear cell type), Kidney	.m	120 to 321	202 to 1				202/202 (100 %)	0 diff (100 %id)
AI363131	anaplastic oligodendroglioma, brain	.m	120 to 568	455 to 7				449/455 (98 %)	1 diff (99.8 %id)
AI343871	2 pooled tumors (clear cell type), Kidney	.m	123 to 566	457 to 14		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	444/444 (100 %)	0 diff (100 %id)
AI355668	lung	.m	123 to 568	449 to 4				446/452 (98 %)	2 diff (99.6 %id)
AI494283	anaplastic oligodendroglioma, brain	.m	123 to 568	453 to 8				446/453 (98 %)	0 diff (100 %id)
AW005664	anaplastic oligodendroglioma, brain	.m	125 to 568	452 to 9				444/452 (98 %)	0 diff (100 %id)
AW117478	pooled	.m	125 to 566	454 to 13		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	442/442 (100 %)	0 diff (100 %id)
AI709080	aorta	.m	131 to 568	439 to 2				438/439 (99 %)	0 diff (100 %id)
AW239094	lung, cell line	.m	132 to 601	1 to 470				470/470 (100 %)	0 diff (100 %id)
D54718		.m	137 to 565	425 to 1				425/425 (100 %)	8 diff (98.2 %id)
BG214137		.m	141 to 565	1 to 426		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	426/426 (100 %)	3 diff (99.3 %id)
AA770648	carcinoid, lung	.m	142 to 566	437 to 15		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	423/448 (94 %)	4 diff (99.2 %id)
AA947950	carcinoid, lung	.m	142 to 563	420 to 1				420/423 (99 %)	4 diff (99.1 %id)
AA533144	normal prostatic epithelial cells, Prostate	.m	144 to 563	419 to 1				419/460 (91 %)	5 diff (99.0 %id)
BM548550	brain, hippocampus	.m	145 to 1103	10 to 979		tiling clone,		970/1120 (86 %)	41 diff (96.4 %id)
AI299979	carcinoid, lung	.m	150 to 566	432 to 16		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	417/417 (100 %)	1 diff (99.8 %id)
CF128690	Chondrosarcoma Lung Metastasis cell lines, lung	.m	150 to 565	1 to 415		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	415/415 (100 %)	1 diff (99.8 %id)
BF791890	adrenal cortex carcinoma, cell line, adrenal gland	.m	153 to 565	1 to 409		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	409/409 (100 %)	5 diff (98.8 %id)
AA884817	pooled	.m	159 to 566	407 to 1				407/410 (99 %)	1 diff (99.8 %id)
AA808457	germinal center B cell	.m	165 to 566	420 to 20		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	401/401 (100 %)	3 diff (99.3 %id)
AI084918	anaplastic oligodendroglioma, brain	.m	165 to 568	404 to 1				404/404 (100 %)	1 diff (99.8 %id)
BU162440	melanotic melanoma, cell line, skin	.m	169 to 566	1 to 398		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	398/398 (100 %)	1 diff (99.8 %id)
AA114924	uterus	.m	171 to 748	35 to 623				589/623 (94 %)	22 diff (96.5 %id)
AI128584	heart	.m	174 to 565	391 to 1				391/391 (100 %)	3 diff (99.3 %id)
BG491397	amelanotic melanoma, cell line, skin	.m	186 to 565	1 to 378		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	378/378 (100 %)	2 diff (99.5 %id)
BM911843	amelanotic melanoma, cell line, skin	.m	188 to 566	1 to 379		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	379/379 (100 %)	0 diff (100 %id)
BM743496	Ascites, stomach	.m	190 to 566	1 to 376		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	376/376 (100 %)	2 diff (99.5 %id)
D52875		.m	192 to 565	372 to 1		fully sequenced,		372/372 (100 %)	5 diff (98.7 %id)
BM670693	eye, fetal eyes	.m	192 to 566	393 to 19		fully sequenced, AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	375/375 (100 %)	0 diff (100 %id)
BE382489	brain, neuroblastoma	.m	196 to 565	1 to 370				370/372 (99 %)	2 diff (99.5 %id)
CF129209	Chondrosarcoma Lung Metastasis cell lines, lung	.m	201 to 566	1 to 366		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	366/366 (100 %)	4 diff (99.0 %id)
BY998907		.m	216 to 568	1 to 353			Submitted on the opposite strand	353/354 (99 %)	1 diff (99.8 %id)
BY998979		.m	216 to 568	1 to 353			Submitted on the opposite strand	353/354 (99 %)	1 diff (99.8 %id)
BG219881		.m	224 to 553	379 to 51		AAA	Submitted on the opposite strand	329/347 (94 %)	5 diff (98.6 %id)
AA724428	pooled	.m	224 to 568	345 to 2				344/345 (99 %)	1 diff (99.8 %id)
F37949	pectoral muscle (after mastectomy)	.m	234 to 565	1 to 332				332/332 (100 %)	5 diff (98.5 %id)
AA491586	Ewing's sarcoma	.m	241 to 566	344 to 20		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	325/325 (100 %)	1 diff (99.7 %id)
AA658037		.m	261 to 351	91 to 1				91/91 (100 %)	0 diff (100 %id)
W73052	heart	.m	263 to 567	305 to 1		fully sequenced,		305/305 (100 %)	0 diff (100 %id)
CN305891	embryonic stem cells, DMSO-treated H9 cellline	.m	278 to 577	1 to 300		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	300/300 (100 %)	0 diff (100 %id)
AA524092	colon	.m	291 to 565	275 to 1				275/275 (100 %)	0 diff (100 %id)
BG212546		.m	292 to 577	1 to 284				284/284 (100 %)	5 diff (98.3 %id)
GD158296		.m	294 to 566	1 to 273		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	273/273 (100 %)	2 diff (99.3 %id)
BG217323		.m	296 to 571	1 to 275		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	275/275 (100 %)	3 diff (99.0 %id)
CN305895	embryonic stem cells, DMSO-treated H9 cellline	.m	297 to 568	1 to 272				272/277 (98 %)	2 diff (99.3 %id)
AA852096	Bone, Hip	.m	299 to 554	266 to 8				259/300 (86 %)	3 diff (99.0 %id)
FN054821	breast carcinoma	.m	313 to 414	102 to 1			Submitted on the opposite strand	102/102 (100 %)	0 diff (100 %id)
AA632937	breast	.m	318 to 559	247 to 6				242/247 (97 %)	0 diff (100 %id)
W81385	heart	.m	321 to 565	246 to 1		fully sequenced,		246/246 (100 %)	0 diff (100 %id)
AA513190	Ewing's sarcoma	.m	323 to 565	1 to 242		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	242/242 (100 %)	5 diff (98.0 %id)
DN602016	human embryonic stem cells	.m	336 to 919	1 to 584		tiling clone,		584/584 (100 %)	0 diff (100 %id)
AA700360	liver and spleen	.m	348 to 566	219 to 1				219/219 (100 %)	1 diff (99.6 %id)
BM667060	eye, fetal eyes	.m	435 to 566	150 to 19		fully sequenced, AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	132/132 (100 %)	0 diff (100 %id)
CD675493	eye, lens	.m	460 to 566	1 to 107		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	107/107 (100 %)	0 diff (100 %id)
AA678104	liver and spleen	.m	992 to 1433	441 to 1		tiling clone,		441/441 (100 %)	2 diff (99.6 %id)
BF739981	Kidney	.m	1094 to 1427	335 to 2				334/335 (99 %)	0 diff (100 %id)
BU584599	stomach	.m	1190 to 1631	445 to 1		tiling clone,		445/445 (100 %)	5 diff (98.9 %id)
AA378419	synovial membrane	.n-u	1 to 341	1 to 343	exact	tiling clone,		343/343 (100 %)	4 diff (98.9 %id)
DA353856	substantia nigra	.o	1 to 573	2 to 574	exact	tiling clone, capped		573/573 (100 %)	1 diff (99.9 %id)
BF961154	nervous_normal	.o	7 to 262	268 to 14				255/277 (92 %)	9 diff (96.8 %id)
BF962530	nervous_normal	.o	7 to 262	289 to 34				256/298 (85 %)	8 diff (97.4 %id)
DA186212	amygdala	.o	35 to 556	2 to 523	exact	tiling clone, capped		522/522 (100 %)	0 diff (100 %id)
BP273012		.p	1 to 443	1 to 443	A3L D6Y	tiling clone, AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	443/443 (100 %)	4 diff (99.1 %id)
AA721776	Ewing's sarcoma	.q	1 to 338	1 to 337	H2D W17C P79Q	tiling clone,		337/344 (97 %)	11 diff (96.9 %id)
AI140018	heart	.r	1 to 375	376 to 2	exact	tiling clone,		375/376 (99 %)	0 diff (100 %id)
DW418401	Liver	.s	1 to 375	10 to 384	T9A	tiling clone,		375/428 (87 %)	12 diff (97.2 %id)
DA293422	hippocampus	.t	1 to 458	2 to 461		tiling clone, capped		460/460 (100 %)	3 diff (99.4 %id)
DA840551	placenta	.t	1 to 441	2 to 442		tiling clone, capped		441/441 (100 %)	1 diff (99.8 %id)
BG326674	Kidney, renal cell adenocarcinoma	.t	39 to 1267	32 to 637		AAA		530/646 (82 %)	39 diff (94.0 %id)
BU661207	blood	.t	404 to 1083	1 to 679		tiling clone,		679/679 (100 %)	5 diff (99.3 %id)
FN071607	breast carcinoma	.t	432 to 494	62 to 1			Submitted on the opposite strand	62/64 (96 %)	1 diff (98.5 %id)
DB504402	hypothalamus	.u	1 to 484	1 to 484	exact	tiling clone,		484/484 (100 %)	1 diff (99.8 %id)
DB575644	hypothalamus	.u	2 to 489	7 to 495	exact	tiling clone,	Submitted on the opposite strand	489/497 (98 %)	7 diff (98.6 %id)
BF747003	breast	.u	28 to 449	434 to 13	Q55P		Submitted on the opposite strand	422/434 (97 %)	2 diff (99.6 %id)
CF124893	CNCAP(3)T-225 cell line, Prostate	.va	1 to 309	287 to 595	exact			309/595 (51 %)	6 diff (99.0 %id)
TI_154185291		.va	1 to 369	349 to 716	exact	tiling clone, AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	368/647 (56 %)	9 diff (98.7 %id)
BE866592	bladder, carcinoma, cell line	.vb-u	1 to 564	1 to 568	C30R G41A F42L R43D C44A ...	tiling clone,		568/812 (69 %)	18 diff (97.8 %id)
DA835273	placenta	.vb-u	72 to 622	2 to 552	exact	tiling clone, capped		551/551 (100 %)	0 diff (100 %id)
AK057119	Spleen	.vb-u	315 to 2267	1 to 1953		tiling clone, available from FLJ,		1953/1953 (100 %)	1 diff (100.0 %id)
DA931232	Spleen	.vb-u	316 to 1184	2 to 866		capped		865/867 (99 %)	15 diff (98.3 %id)
BX093383	melanocyte	.vb-u	812 to 1553	1 to 743				743/743 (100 %)	1 diff (99.9 %id)
CN430726	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.vb-u	1080 to 1706	1 to 628		tiling clone,		628/628 (100 %)	3 diff (99.6 %id)
BC062446	Skin and meninges pool- skin, dura matter,pia matter, choroid plexus.	.vb-u	1185 to 1828	1 to 644		available from MGC, AAA		644/644 (100 %)	3 diff (99.6 %id)
CB998995	Pooled-Skin	.vb-u	1186 to 1824	1 to 643		available from MGC, AAA		643/879 (73 %)	7 diff (99.3 %id)
EL952917	eyeball	.vb-u	1200 to 1659	51 to 510				460/510 (90 %)	8 diff (98.5 %id)
BG946615	bladder_tumor	.vb-u	1342 to 1705	25 to 386				362/389 (93 %)	11 diff (97.2 %id)
BM687849	eye, Retina Foveal and Macular	.vb-u	1360 to 1722	6 to 368				363/368 (98 %)	6 diff (98.4 %id)
AI042495	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.vb-u	1381 to 1839	459 to 1				459/459 (100 %)	2 diff (99.6 %id)
AI123248	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.vb-u	1381 to 1837	458 to 1				458/458 (100 %)	2 diff (99.6 %id)
N21682	melanocyte	.vb-u	1384 to 1839	463 to 1				463/463 (100 %)	10 diff (97.9 %id)
AI042496	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.vb-u	1415 to 1839	425 to 1				425/425 (100 %)	3 diff (99.3 %id)
AI377541	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.vb-u	1443 to 1837	395 to 1				395/395 (100 %)	0 diff (100 %id)
DB332431	Spleen	.vb-u	1822 to 2267	450 to 1				450/450 (100 %)	11 diff (97.6 %id)
BI667312	brain, hypothalamus	.vb-u	1834 to 2267	1 to 434		available from MGC, AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	434/434 (100 %)	5 diff (98.9 %id)
DB560843	hypothalamus	.vb-u	1839 to 2267	15 to 445			Submitted on the opposite strand	431/445 (96 %)	6 diff (98.7 %id)
TI_44343662		.vb-u	1839 to 2267	88 to 516		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	429/516 (83 %)	6 diff (98.9 %id)
BC039451	Brain, hypothalamus	.vb-u	1848 to 2267	10 to 429		available from MGC, AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	420/420 (100 %)	0 diff (100 %id)
AK090764	alzheimer cortex	.vc	1 to 1870	2 to 1871	exact	tiling clone, available from FLJ,		1871/1871 (100 %)	3 diff (99.9 %id)
DA129393	alzheimer cortex	.vc	1 to 420	2 to 421		capped		420/420 (100 %)	0 diff (100 %id)
BG913893	anaplastic oligodendroglioma with 1p/19qloss, brain	.vc	84 to 814	12 to 753				742/818 (90 %)	6 diff (99.3 %id)
BG960563	colon	.vc	166 to 529	364 to 2				363/364 (99 %)	0 diff (100 %id)
AL601629		.vc	207 to 622	1 to 416				416/416 (100 %)	1 diff (99.8 %id)
BF356652	head_neck	.vc	235 to 541	1 to 306				306/313 (97 %)	5 diff (98.5 %id)
BF356650	head_neck	.vc	237 to 541	1 to 305				305/310 (98 %)	3 diff (99.1 %id)
AL599586		.vc	244 to 533	1 to 290				290/290 (100 %)	5 diff (98.3 %id)
BF352442	head_neck	.vc	263 to 648	401 to 16				386/401 (96 %)	0 diff (100 %id)
DA080878	cerebellum	.vc	317 to 886	2 to 571		capped		570/570 (100 %)	0 diff (100 %id)
FN141504	breast carcinoma	.vc	332 to 385	1 to 55				55/56 (98 %)	2 diff (96.5 %id)
BE168679	head_neck	.vc	366 to 526	6 to 164				159/164 (96 %)	7 diff (95.8 %id)
BX954261		.vc	373 to 977	1 to 605				605/605 (100 %)	1 diff (99.9 %id)
CD519114	White Matter	.vc	421 to 1189	1 to 779				779/885 (88 %)	12 diff (98.7 %id)
CR747885	Kidney	.vc	698 to 1317	1 to 621		tiling clone,		621/621 (100 %)	1 diff (99.9 %id)
BF368286	placenta_normal	.vc	730 to 909	1 to 179				179/179 (100 %)	10 diff (94.5 %id)
BG001820	placenta_normal	.vc	734 to 909	20 to 194				175/194 (90 %)	6 diff (97.0 %id)
BQ321413	colon	.vc	735 to 830	10 to 104				95/104 (91 %)	6 diff (94.3 %id)
BQ376278	testis_normal	.vc	740 to 914	17 to 190				174/204 (85 %)	14 diff (93.2 %id)
BF368284	placenta_normal	.vc	744 to 924	192 to 13				180/192 (93 %)	0 diff (100 %id)
BF376646	testis_normal	.vc	744 to 886	149 to 7				143/149 (95 %)	0 diff (100 %id)
BG001812	placenta_normal	.vc	744 to 907	165 to 3				163/165 (98 %)	0 diff (100 %id)
BG001819	placenta_normal	.vc	744 to 909	167 to 1				167/167 (100 %)	3 diff (98.3 %id)
EH326758		.vc	768 to 837	1 to 69				69/69 (100 %)	1 diff (98.6 %id)
TI_57167357		.vc	820 to 1517	32 to 730				699/730 (95 %)	6 diff (99.2 %id)
BI835262	pooled pancreas and spleen	.vc	821 to 1517	1 to 698				698/698 (100 %)	3 diff (99.6 %id)
BF354042	head_neck	.vc	938 to 1148	1 to 211				211/220 (95 %)	6 diff (97.3 %id)
AW179324	stomach	.vc	1251 to 1749	504 to 2	F2V S3F S5Q M6L L7C ...			503/504 (99 %)	13 diff (97.5 %id)
BQ640607	eye, retina	.vc	1276 to 1841	1 to 569	exact			569/569 (100 %)	4 diff (99.3 %id)
AA663765	schizophrenic brain S-11 frontal lobe	.vc	1306 to 1686	1 to 381			Submitted on the opposite strand	381/388 (98 %)	4 diff (99.0 %id)
AA932194	Kidney	.vc	1409 to 1872	467 to 5	exact	tiling clone,		463/467 (99 %)	1 diff (99.8 %id)
DB301007	alzheimer cortex	.vc	1419 to 1870	452 to 1	C22X			452/452 (100 %)	1 diff (99.8 %id)
AI002307	carcinoid, lung	.vc	1446 to 1870	448 to 25	V23S H24I W25G T26Q T27Q ...	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	424/424 (100 %)	3 diff (99.3 %id)
TI_1242414576		.vd-u	1 to 1073	59 to 1126	exact	tiling clone,		1068/1198 (89 %)	6 diff (99.5 %id)
TI_1242418488		.vd-u	1 to 964	62 to 1024	exact			963/1024 (94 %)	6 diff (99.5 %id)
BM697797	eye, fetal eyes	.vd-u	343 to 840	1 to 498	exact			498/498 (100 %)	0 diff (100 %id)
BU736087	eye, fetal eyes	.vd-u	1222 to 1767	564 to 19		tiling clone, AAA		546/546 (100 %)	0 diff (100 %id)
AA703189	liver and spleen	.vd-u	1271 to 1756	488 to 3				486/488 (99 %)	0 diff (100 %id)
BX108020	placenta	.vd-u	1272 to 1756	1 to 485		AAA		485/485 (100 %)	0 diff (100 %id)
R22532	placenta	.vd-u	1272 to 1511	1 to 239		fully sequenced,		239/239 (100 %)	1 diff (99.6 %id)
AI808289	pooled	.vd-u	1284 to 1735	493 to 43		AAA		451/479 (94 %)	0 diff (100 %id)
AI911219	pooled	.vd-u	1305 to 1756	453 to 2				452/453 (99 %)	0 diff (100 %id)
AI635379	pooled germ cell tumors	.vd-u	1313 to 1768	456 to 1				456/703 (64 %)	0 diff (100 %id)
AW043558	pooled	.vd-u	1315 to 1756	443 to 2				442/443 (99 %)	0 diff (100 %id)
AW389519	stomach	.vd-u	1326 to 1723	417 to 20				398/417 (95 %)	0 diff (100 %id)
AA603979	Prostate, prostate tumor	.vd-u	1340 to 1756	419 to 3				417/419 (99 %)	0 diff (100 %id)
AA865115	germinal center B cell	.vd-u	1412 to 1763	374 to 23		AAA		352/352 (100 %)	0 diff (100 %id)
R09760	liver and spleen	.vd-u	1413 to 1756	354 to 5				350/432 (81 %)	0 diff (100 %id)
AW173088	pooled	.vd-u	1424 to 1763	354 to 15		AAA		340/340 (100 %)	2 diff (99.5 %id)
AI620801	Prostate	.vd-u	1426 to 1768	346 to 4				343/346 (99 %)	0 diff (100 %id)
R22533	placenta	.vd-u	1481 to 1757	281 to 1		fully sequenced,		281/281 (100 %)	7 diff (97.6 %id)
BM980889	lung, Primary Lung Cystic Fibrosis EpithelialCells	.vd-u	1608 to 1776	187 to 19		tiling clone, AAA		169/169 (100 %)	0 diff (100 %id)
DB458220. matches multiple genes	testis	.ve	1 to 479	3 to 481	exact	tiling clone,	also hits gene karee	481/481 (100 %)	2 diff (99.6 %id)
BG719958	testis	.ve	8 to 784	1 to 779				779/779 (100 %)	7 diff (99.2 %id)
BC005331	Brain, primitive neuroectodermal	.ve	14 to 1432	1 to 1419		tiling clone, available from MGC, AAA		1419/1419 (100 %)	3 diff (99.8 %id)
BE958533	brain, primitive neuroectoderm	.ve	33 to 719	1 to 693		available from MGC,		693/711 (97 %)	26 diff (96.4 %id)
BF978458	melanotic melanoma, high MDR, skin	.ve	33 to 755	1 to 717				717/890 (80 %)	14 diff (98.5 %id)
BG494911	lung, mucoepidermoid carcinoma	.ve	33 to 704	1 to 673				673/673 (100 %)	3 diff (99.6 %id)
BF029378	bladder, carcinoma, cell line	.ve	42 to 588	1 to 566				562/618 (90 %)	36 diff (94.2 %id)
BG686505	B-cells, primary B-cells from tonsils (cell line)	.ve	63 to 702	1 to 640		available from MGC,		640/642 (99 %)	2 diff (99.7 %id)
BC023654	Primary B-Cells from Tonsils	.ve	64 to 1428	1 to 1365		available from MGC, AAA		1365/1365 (100 %)	1 diff (100.0 %id)
BU193581	melanotic melanoma, skin	.ve	72 to 929	8 to 872		available from MGC,		865/888 (97 %)	21 diff (97.7 %id)
R09949	liver and spleen	.ve	75 to 430	1 to 372				372/372 (100 %)	25 diff (93.3 %id)
BF795813	lymph, lymphoma, cell line	.ve	75 to 780	12 to 713				702/935 (75 %)	21 diff (97.8 %id)
BC053556	Skin, melanotic melanoma.	.ve	76 to 1421	1 to 1346		available from MGC, AAA		1346/1346 (100 %)	0 diff (100 %id)
BU165976	melanotic melanoma, skin	.ve	78 to 819	12 to 760				749/921 (81 %)	16 diff (98.3 %id)
BC011632	Skin, melanotic melanoma.	.ve	84 to 1421	1 to 1338		available from MGC, AAA		1338/1338 (100 %)	0 diff (100 %id)
CX752385	Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass	.ve	93 to 782	1 to 690			Submitted on the opposite strand	690/690 (100 %)	0 diff (100 %id)
CN257896	embryonic stem cells, DMSO-treated H9 cellline	.ve	100 to 848	1 to 750				750/750 (100 %)	4 diff (99.5 %id)
BF125817	melanotic melanoma, skin	.ve	104 to 786	1 to 682		available from MGC,		682/917 (74 %)	15 diff (98.4 %id)
BQ434316	melanotic melanoma, skin	.ve	117 to 998	5 to 888				884/888 (99 %)	15 diff (98.4 %id)
CN257900	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.ve	119 to 719	1 to 601				601/601 (100 %)	0 diff (100 %id)
BF724265	eye, Iris	.ve	309 to 697	1 to 389				389/389 (100 %)	4 diff (99.0 %id)
CN257898	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.ve	337 to 944	1 to 610				610/610 (100 %)	5 diff (99.2 %id)
R12589	liver and spleen	.ve	677 to 984	318 to 5				314/372 (84 %)	0 diff (100 %id)
BU628809	Bone, Enchondroma cell line	.ve	687 to 1432	763 to 19		AAA		745/745 (100 %)	4 diff (99.5 %id)
CA425939	cell lines, Chondrosarcoma	.ve	735 to 1421	705 to 19		AAA		687/687 (100 %)	1 diff (99.9 %id)
BU628165	Bone, Enchondroma cell line	.ve	774 to 1432	677 to 19		AAA		659/659 (100 %)	3 diff (99.6 %id)
FN106893	breast carcinoma	.ve	790 to 874	1 to 85				85/85 (100 %)	0 diff (100 %id)
TI_59393552		.ve	814 to 1431	46 to 662		AAA		617/617 (100 %)	7 diff (98.9 %id)
BM015322	breast, mammary adenocarcinoma, cell line	.ve	815 to 1431	1 to 616		AAA		616/616 (100 %)	7 diff (98.9 %id)
DA355646	subthalamic nucleus	.vf	1 to 558	2 to 560	S24F W25L T26D I27D	tiling clone, capped		559/559 (100 %)	1 diff (99.9 %id)
CD236983	Pituitary	.vf	2 to 692	1 to 691	exact			691/691 (100 %)	1 diff (99.9 %id)
AX721172		.vf	15 to 1302	1 to 1286	exact	tiling clone,		1286/1286 (100 %)	3 diff (99.8 %id)
BC045166	Breast, mammary adenocarcinoma.	.vf	50 to 354	1 to 305	exact	available from MGC, AAA		305/305 (100 %)	0 diff (100 %id)
TI_59394567		.vf	50 to 354	90 to 394	exact	AAA		305/305 (100 %)	0 diff (100 %id)
BM016174	breast, mammary adenocarcinoma, cell line	.vf	51 to 354	1 to 304	exact	available from MGC, AAA		304/304 (100 %)	0 diff (100 %id)
BU159127	eye, retinoblastoma	.vf	57 to 606	1 to 559	exact			559/784 (71 %)	25 diff (96.9 %id)
DB310473	subthalamic nucleus	.vf	788 to 1301	514 to 1		tiling clone,		514/514 (100 %)	2 diff (99.7 %id)
BU169268	epidermoid carcinoma, cell line, salivary gland	.vg	1 to 771	1 to 771	exact	tiling clone, AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	771/771 (100 %)	0 diff (100 %id)
BU169264	epidermoid carcinoma, cell line, salivary gland	.vg	3 to 771	34 to 803	exact	AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	770/804 (95 %)	10 diff (98.8 %id)
CN364892	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.vh	1 to 702	1 to 702	exact	tiling clone,		702/702 (100 %)	1 diff (99.9 %id)
DA295533	hippocampus	.vi-u	1 to 564	2 to 564	exact	tiling clone, capped		563/563 (100 %)	2 diff (99.7 %id)
DA776145	brain	.vi-u	136 to 699	2 to 565	exact	tiling clone, capped		564/564 (100 %)	0 diff (100 %id)
CK004424	brain/CNS, Human Brain - Frontal Cortex	.vj	1 to 601	1 to 600	exact	tiling clone,		600/601 (99 %)	5 diff (99.2 %id)
DA094429	cerebellum	.vj	10 to 564	2 to 557	C42X A43C I44H C45L R46Q ...	capped		556/556 (100 %)	2 diff (99.7 %id)
DA370082	subthalamic nucleus	.vj	10 to 565	2 to 557	exact	capped		556/556 (100 %)	2 diff (99.7 %id)
BI223624	cervical carcinoma cell line, cervix	.vj	11 to 678	1 to 670	S11E G12R T13H N14Q S15Q ...			670/730 (91 %)	12 diff (98.4 %id)
AI814515	lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic)	.vj	98 to 682	597 to 13		AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	585/589 (99 %)	2 diff (99.7 %id)
AA812938		.vj	229 to 684	462 to 8				455/462 (98 %)	2 diff (99.6 %id)
AA852095	Bone, Hip	.vj	236 to 531	9 to 303				295/303 (97 %)	3 diff (99.1 %id)
BF512968		.vj	249 to 687	456 to 18		tiling clone, AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	439/439 (100 %)	0 diff (100 %id)
BF918069	uterus_tumor	.vk-u	1 to 197	1 to 197		tiling clone,		197/197 (100 %)	4 diff (98.0 %id)
AI860168	lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic)	.vk-u	146 to 607	463 to 1		tiling clone,		463/463 (100 %)	10 diff (97.9 %id)
DA352140	substantia nigra	.vl	1 to 542	2 to 543	exact	tiling clone, capped		542/542 (100 %)	0 diff (100 %id)
TI_57164904		.vm	1 to 446	34 to 480	H19Q	tiling clone, AAA	Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)	447/480 (93 %)	9 diff (98.2 %id)
AW161517	brain, frontal lobe	.vm	7 to 446	1 to 440	exact	tiling clone,		440/442 (99 %)	1 diff (99.8 %id)
AW161957	brain, frontal lobe	.vm	7 to 425	1 to 419	exact			419/419 (100 %)	0 diff (100 %id)
AW163628	brain, frontal lobe	.vm	7 to 442	1 to 436	exact			436/436 (100 %)	0 diff (100 %id)
AA843156	parathyroid gland, parathyroid tumor	.vm	56 to 449	398 to 6	exact			393/398 (98 %)	1 diff (99.8 %id)
AA570209		.vn-u	1 to 387	1 to 385	I2T S7G	tiling clone,		385/387 (99 %)	6 diff (98.5 %id)
AW177678	colon	Gene XPNPEP3andRBX1, variant not shown					This clone was ignored
BX648018	human retina	Gene XPNPEP3andRBX1, variant not shown				available from DKFZ, AAA	This clone was ignored
BC032537. matches multiple genes	Skin, melanotic melanoma.	Gene lorga, variant not shown				available from MGC, AAA	This clone was ignored, also hits gene lorga
BC032537. matches multiple genes	Skin, melanotic melanoma.	Gene XPNPEP3andRBX1, variant not shown				available from MGC, AAA	This clone was ignored, also hits gene lorga

155 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.